Clinical trial
AI-derived Retinal Quantification Versus Routine Clinical Interpretation in Ophthalmic Assessment: a Randomized Controlled Trial
NCT07291960 is registered in ClinicalTrials.gov with Beijing Tongren Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AI-derived Retinal Quantification Versus Routine Clinical Interpretation in Ophthalmic Assessment: a Randomized Controlled Trial
- Lead sponsor
- Beijing Tongren Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 15, 2026
- Completion date
- May 15, 2026
- Enrollment
- 29 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
amd, cup-to-disc ratio bigger than 0.5, diabetic retinopathy (dr), epiretinal membrane, macular hole, no obvious abnormalities, pathological myopia, retinal vein occlusion (rvo)